Last reviewed · How we verify
Alcoholism
Approved treatments
- Tetrucid
Tetrucid works by inhibiting the enzyme aldehyde dehydrogenase, which breaks down alcohol into a less toxic compound. - Campral · Allergan/AbbVie
Campral works by modulating the activity of the GABA-A receptor, a key neurotransmitter system involved in regulating alcohol cravings and withdrawal symptoms. - Naltrexon · Institute of Liver and Biliary Sciences, India
- Antabuse
- Revex · Hikma
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Alcoholism patent landscape — cliff calendar, originator estates, attackable patents
- Alcoholism treatment landscape brief
- Alcoholism treatment updates RSS
Frequently asked questions about Alcoholism
What drugs treat Alcoholism?
Tracked treatments include Tetrucid, Campral, Naltrexon, Antabuse, Revex.
What is the treatment for Alcoholism?
Standard treatment for Alcoholism includes Tetrucid, Campral, Naltrexon, Antabuse, Revex. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Alcoholism patent cliff · Alcoholism CI report
- Treatment: Tetrucid
- Treatment: Campral · Allergan/AbbVie
- Treatment: Naltrexon · Institute of Liver and Biliary Sciences, India
- Treatment: Antabuse
- Treatment: Revex · Hikma
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing